Abstract:Chemokines are a group of small, structurally related molecules that regulate the trafficking of various types of leukocytes through interactions with a subset of 7-transmembrane G-protein-coupled receptors. As key chemoattractants of inflammatory leukocytes, chemokines have been marked as potential targets for neutralization in autoimmune diseases. Cancer cells also express chemokines, where they function as survival/growth factors and/or angiogenic factors that promote tumor development and angiogenesis. Accordingly, these functions make them attractive targets for therapy of these diseases. Recently, we reported that one of these chemokines CXCL12 (SDF-1alpha) functions as an anti-inflammatory chemokine during autoimmune inflammatory responses and explored the mechanistic basis of this function. As a pleiotropic chemokine, CXCL12 participates in the regulation of tissue homeostasis, immune surveillance, autoimmunity, and cancer. This chemokine is constitutively expressed in the BM and various tissues, which enables it to regulate the trafficking and localization of immature and maturing leukocytes, including BM stem cells, neutrophils, T cells, and monocytic cells. We have shown recently that CXCL12 increases immunological tolerance in autoimmune diseases by polarizing Tregs and by doing so, restrains the progression of these diseases. This finding suggests a possible use of stabilized rCXCL12 as a potential drug for therapy of these diseases and targeted neutralization of CXCL12 for therapy of cancer diseases. The current review explores the different biological properties of CXCL12 and discusses the implications of CXCL12-based therapies for autoimmunity and cancer diseases.

CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer

CXCL13-CXCR5 Axis: Regulation in Inflammatory Diseases and Cancer.

CXCL13-CXCR5 axis：regulation in inflammatory diseases and cancer

CXCL13: a common target for immune-mediated inflammatory diseases

Regulative Role of the CXCL13-CXCR5 Axis in the Tumor Microenvironment

Clinical Significance of CXCL13/CXCR5 Axis in Human Cancers

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

Role of CX3CL1 in Diseases

CXCL3: A key player in tumor microenvironment and inflammatory diseases

Potential Roles and Targeted Therapy of the CXCLs/CXCR2 Axis in Cancer and Inflammatory Diseases

The multiple faces of CXCL12 (SDF-1α) in the regulation of immunity during health and disease

The Role of CXCR3 and Its Ligands in Cancer

Revisiting the CXCL13/CXCR5 Axis in the Tumor Microenvironment in the Era of Single-cell Omics: Implications for Immunotherapy

CCL5/CCR5 axis in human diseases and related treatments

CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer

CXCL6: A potential therapeutic target for inflammation and cancer

CXCL13 and Malignant Tumors

CCL13 and human diseases

The CXCL12 (SDF-1)/CXCR4 Chemokine Axis: Oncogenic Properties, Molecular Targeting, and Synthetic and Natural Product CXCR4 Inhibitors for Cancer Therapy.

Multifaceted Roles of Chemokine C-X-C Motif Ligand 7 in Inflammatory Diseases and Cancer